BSF Enterprise and the University of Montreal Advance Lab-Grown Cornea Development

Partnership Accelerates Cutting-Edge Corneal Research

BSF Enterprise PLC, a London-based biotech company, and the University of Montreal have joined forces to enhance the development of lab-grown corneas. This collaboration aims to revolutionize the treatment of corneal damage and provide innovative solutions for a growing medical need.

Novel Approach to Corneal Damage

Kerato Ltd, a subsidiary of BSF Enterprise, is leading the charge in the development of lab-grown corneas. This advanced technique offers a promising alternative to traditional corneal transplants, overcoming the limitations of donor tissue availability and potential immune rejection. By leveraging the expertise of the University of Montreal, Kerato will accelerate its research and development efforts, bringing this novel treatment closer to clinical application.